highperformr logo

Astellas Pharma's Overview

Total employees11663
HeadquartersChuo-ku, Tokyo
Founded

Astellas Pharma Inc. is a global pharmaceutical company headquartered in Tokyo, Japan, dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The company's business philosophy is to contribute to the health of people worldwide by discovering and developing innovative new medicines. Astellas focuses on therapeutic areas with high unmet medical needs, including Oncology, Urology, Immunology (including transplantation), Nephrology, and Neuroscience, as well as advancing new technological approaches and research into new modalities.

Where is Astellas Pharma's Headquarters?

HQ Function

Serves as the global headquarters, overseeing strategic planning, corporate governance, global R&D direction, financial management, and worldwide operations.

Notable Features:

Modern office facilities designed to foster collaboration and innovation, strategically located in Tokyo's business district.

Work Culture:

Emphasis on scientific excellence, ethical conduct, patient-centricity ('Patient anshin'), and fostering a culture of open innovation. Collaborative environment with a focus on global teamwork.

HQ Significance:

Central hub for global decision-making, setting the company's long-term vision, and coordinating activities across all regions and functions.

Values Reflected in HQ: The headquarters design and operations likely reflect Astellas' commitment to innovation, integrity, and global collaboration in its mission to improve patient health.

Location:

Astellas Pharma Inc. operates globally with a significant presence in Japan, the Americas (North and South America), EMEA (Europe, Middle East, Africa), and Asia/Oceania. Key global functions supported include research and development (with major research sites in Japan and the U.S.), manufacturing facilities in several countries, and sales and marketing operations tailored to local markets worldwide. This extensive network enables Astellas to discover, develop, manufacture, and commercialize innovative treatments for patients across diverse geographies.

Street Address:

2-5-1, Nihonbashi-Honcho

City:

Chuo-ku, Tokyo

State/Province:

Tokyo

Country:

Japan

Astellas Pharma's Global Presence

Northbrook, Illinois, USA

Address: 1 Astellas Way, Northbrook, IL 60062, USA

Manages development, manufacturing, and commercialization of pharmaceutical products for the U.S. and broader Americas market, adapting global strategies to regional needs.

Chertsey, Surrey, UK

Address: 2000 Hillswood Drive, Chertsey, Surrey, KT16 0RS, UK

Drives commercial strategy, market access, and medical affairs for Astellas' portfolio within the EMEA region, ensuring compliance with diverse regulatory environments.

Markham, Ontario, Canada

Address: 200 Middlefield Road, Suite 200, Markham, ON L3S 0C1, Canada

Focuses on bringing Astellas' innovative medicines to Canadian patients and healthcare providers, navigating the Canadian pharmaceutical landscape.

Buying Intent Signals for Astellas Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Astellas Pharma

As of April 2025, Astellas Pharma' leadership includes:

Naoki Okamura - Representative Director, President and CEO
Minoru Ohta - Representative Director, Executive Vice President, CFO
Claus Zieler - Senior Corporate Executive, Chief Strategy Officer (CStO)
Nick Lagunowich - Senior Corporate Executive, Chief Commercial Officer (CCO)
Tadaaki Taniguchi - Senior Corporate Executive, Chief Medical Officer (CMO)
Yoshitsugu Shitaka - Senior Corporate Executive, Chief Scientific Officer (CScO)

Investors of Astellas Pharma

Astellas Pharma has been backed by several prominent investors over the years, including:

The Master Trust Bank of Japan, Ltd. (Trust Account)
Custody Bank of Japan, Ltd. (Trust Account)
Nippon Life Insurance Company
State Street Bank West Client - Treaty 505234
JP MORGAN CHASE BANK 385632
BlackRock Inc.
The Vanguard Group, Inc.

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Astellas has seen key leadership transitions aimed at strengthening its strategic focus and commercial execution. Notable changes include appointments to Chief Commercial Officer and Chief Financial Officer roles.

Departures

Atsushi Kitamura, Atsushi Kitamura retired from his role as CFO.

New Appointments:

Nick Lagunowich, Nick Lagunowich appointed as Chief Commercial Officer.
Claus Zieler, Claus Zieler transitioned to the new role of Chief Strategy Officer.
Minoru Ohta, Minoru Ohta appointed as Chief Financial Officer.

Technology (Tech Stack) used by Astellas Pharma

Discover the tools Astellas Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Astellas Pharma Email Formats and Examples

Astellas Pharma Inc. primarily uses the 'first.last@astellas.com' email format for its employees globally. Variations may exist, but this is the most common structure.

first.last@astellas.com

Format

john.smith@astellas.com

Example

90%

Success rate

News and media

Astellas Pharma Inc. NewsMay 13, 2024

Astellas Pharma Inc. News: Astellas and Kelonia Therapeutics Announce Research Collaboration and License Agreement to Develop Novel Immuno-Oncology Therapeutics

Astellas Pharma Inc. and Kelonia Therapeutics today announced a research collaboration and license agreement to develop novel immuno-oncology therapeutics. The collaboration will focus on generating innovative in vivo CAR T cell therapies for cancer....more

Astellas Pharma Inc. NewsApril 1, 2024

Astellas Pharma Inc. News: Astellas Announces New Executive Leadership Structure

Astellas announced changes to its executive leadership effective April 1, 2024, including the appointment of Nick Lagunowich as Chief Commercial Officer and Claus Zieler as Chief Strategy Officer, alongside Minoru Ohta as Chief Financial Officer. These changes aim to accelerate growth and enhance strategic execution....more

Astellas Pharma Inc. NewsFebruary 5, 2024

Astellas Pharma Inc. News: FDA Approves Astellas’ VEOZAH™ (fezolinetant) for the Treatment of Vasomotor Symptoms Due to Menopause

Astellas announced that the U.S. Food and Drug Administration (FDA) approved VEOZAH™ (fezolinetant) 45 mg once daily for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. VEOZAH is the first and only nonhormonal neurokinin 3 (NK3) receptor antagonist approved to treat VMS due to menopause....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Astellas Pharma, are just a search away.